BDX vs XWEL · P/E 34, rev $21.84B vs rev $13.8M
Becton Dickinson and Company (BDX) versus XWELL Inc. (XWEL) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
XWELL Inc. (XWEL) is a diagnostics & research company listed on NASDAQ.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Latest reported XWEL revenue for 2026-06-30 was $13.8M. Net income was -$13.4M. XWEL currently screens at market cap $10.4M.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. XWEL currently screens at market cap $10.4M.
Not investment advice. Open the BDX and XWEL stock pages for the full models.
Not investment advice.